These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34191189)

  • 41. Is positron emission tomography enough to rule out cardiac sarcoidosis? A case report.
    Huang S; Kunchakarra S; Rathod A
    Eur Heart J Case Rep; 2021 Sep; 5(9):ytab300. PubMed ID: 34557632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.
    Beliveau P; Cheriet F; Anderson SA; Taylor JL; Arai AE; Hsu LY
    Comput Biol Med; 2015 Oct; 65():103-13. PubMed ID: 26313531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction.
    Murtagh G; Laffin LJ; Patel KV; Patel AV; Bonham CA; Yu Z; Addetia K; El-Hangouche N; Maffesanti F; Mor-Avi V; Hogarth DK; Sweiss NJ; Beshai JF; Lang RM; Patel AR
    Echocardiography; 2016 Sep; 33(9):1344-52. PubMed ID: 27677642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive Male Triathletes With Normal Ejection Fraction.
    Tahir E; Starekova J; Muellerleile K; Freiwald E; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Adam G; Simon P; Pressler A; Patten M; Lund GK
    Circ J; 2019 Jun; 83(7):1553-1562. PubMed ID: 31080228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
    Takashio S; Yamamuro M; Uemura T; Utsunomiya D; Morita K; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Yasuda O; Yamashita Y; Ogawa H
    Am J Cardiol; 2014 May; 113(10):1697-704. PubMed ID: 24698466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship Between Fragmented QRS Complex and Left Ventricular Fibrosis and Function in Patients With Danon Disease.
    Xie J; Liu Y; Wei X; Ye W; Ma Z; Lu G; Tan Z; Li T; Wang Y; Zhao L; Lu M; Li X; Chen Y; Liu H
    Front Cardiovasc Med; 2022; 9():790917. PubMed ID: 35299984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting adverse cardiac events in sarcoidosis: deep learning from automated characterization of regional myocardial remodeling.
    Lu C; Wang YG; Zaman F; Wu X; Adhaduk M; Chang A; Ji J; Wei T; Suksaranjit P; Christodoulidis G; Scalzetti E; Han Y; Feiglin D; Liu K
    Int J Cardiovasc Imaging; 2022 Aug; 38(8):1825-1836. PubMed ID: 35194707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis on related factors of myocardial fibrosis in patients with hypertrophic cardiomyopathy].
    Zhang Y; Wu KH; Li Q; Zhang HJ; Shang YY; Pang MJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Jan; 49(1):31-36. PubMed ID: 33429483
    [No Abstract]   [Full Text] [Related]  

  • 51. Focal Myocardial Damage in Cardiac Sarcoidosis Characterized by Strain Analysis on Magnetic Resonance Tagged Imaging in Comparison with Fluorodeoxyglucose Positron Emission Tomography Accumulation and Magnetic Resonance Late Gadolinium Enhancement.
    Watanabe Y; Nishii T; Shimoyama S; Ito T; Mori S; Kono AK; Takahashi S; Hirata KI; Sugimura K
    J Comput Assist Tomogr; 2018; 42(4):607-613. PubMed ID: 29613987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regional myocardial work by cardiac magnetic resonance and non-invasive left ventricular pressure: a feasibility study in left bundle branch block.
    Larsen CK; Aalen JM; Stokke C; Fjeld JG; Kongsgaard E; Duchenne J; Degtiarova G; Gheysens O; Voigt JU; Smiseth OA; Hopp E
    Eur Heart J Cardiovasc Imaging; 2020 Feb; 21(2):143-153. PubMed ID: 31599327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of Myocardial Viability in Ischemic Heart Disease by PET/MRI: Comparison of Left Ventricular Perfusion, Hibernation, and Scar Burden.
    Beitzke D; Rasul S; Lassen ML; Pichler V; Senn D; Stelzmüller ME; Nolz R; Loewe C; Hacker M
    Acad Radiol; 2020 Feb; 27(2):188-197. PubMed ID: 31053482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography.
    Kawakatsu N; Suzuki A; Serizawa N; Suzuki T; Ejima K; Shiga T; Fukushima K; Momose M; Uto K; Shoda M; Hagiwara N
    J Cardiol Cases; 2016 Oct; 14(4):107-110. PubMed ID: 30524562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study.
    Palazzuoli A; Beltrami M; Gennari L; Dastidar AG; Nuti R; McAlindon E; Angelini GD; Bucciarelli-Ducci C
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):1037-44. PubMed ID: 25863669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
    Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.